Activities

  • PsA+COVID-19: Augmented Reality and Patient Engagement in the Treatment of Psoriatic Arthritis

    COVID-19 has impacted psoriatic arthritis (PsA) patient care in many ways, particularly for patients with multiple comorbidities. This interactive activity reviews clinical practice guidelines addressing COVID-19 infection and vaccination that are relevant to patients with PsA, highlights effectiveness and safety of therapies for PsA, and offers a self-directed experience of building and solving patient cases to learn from making decisions and receiving immediate feedback. This activity also incorporates the patient perspective, a skill-oriented presentation on engaging patients in shared decision making, decision aids, and a demonstration of an augmented reality (AR) app on PsA for healthcare providers and patients.

    Please download the ImmerseRx: Psoriatic Arthritis augmented reality app on your mobile device to gain the most benefit from participation in this activity. You may use one of the QR codes below or search for it in the Google Play or App Store

    Scan for Google Play Store Scan for Apple Store

    This activity is one of four in this series, PsA+COVID-19: Innovations and Tools for Patient-Centered Psoriatic Arthritis Care.

    For the best experience, use a laptop, desktop, or tablet with the Google Chrome browser.

    Release Date: June 14, 2021
    Expiration Date: June 14, 2022

  • PsA+COVID-19: Virtual Solutions and Personalized Learning That Optimize Psoriatic Arthritis Care

    The COVID-19 pandemic has added uncertainty and complexity to providing care to patients with psoriatic disease. Appropriate use of strategies and tools that support providing rheumatology care remotely is critical in today’s clinical encounters. This educational activity addresses these issues through a variety of innovative experiences. First, Dr. Philip Mease and Dr. Alvin Wells present a fascinating look at immune activation and targeted therapies in psoriatic arthritis (PsA) through augmented reality. Participants are invited to join this experience via their mobile device. The activity also features a concise overview of the latest American College of Rheumatology’s clinical practice guidelines related to COVID-19, a self-directed exercise in building and exploring patient cases, and best practices for telemedicine. 

    To gain the most benefit from participation in this activity, please download the ImmerseRx: Psoriatic Arthritis augmented reality app on your mobile device. You may use one of the QR codes below or search for it in the Google Play or App Store. You may also find it helpful to download and print the worksheet before starting the activity. 

    Scan for Google Play Store Scan for Apple Store

    Release Date: March 25, 2021
    Valid Until Date: March 25, 2022

  • Share, Learn, Engage: Novel Targeted Therapies in the Treatment of Systemic Lupus Erythematosus

    Immerse yourself in this 60-minute interactive activity to meet a patient with systemic lupus erythematosus (SLE), view concise presentations, and engage in hands-on experience with the content. This activity will highlight the immunopathogenesis of SLE and mechanisms of action of therapies. Additionally, leading clinical experts will review clinical trial data and outcomes, both available and emerging, and translate them into clinically meaningful information for patient careThis activity is one of two in the series, Systemic Lupus Erythematosus: Patient-Centered Care to Improve Disease Control. 

    Release Date: May 21, 2021
    Valid Until: May 21, 2022

    For the best experience, use a laptop, desktop, or tablet with the Google Chrome browser. 

  • Share, Learn, Engage: Setting and Achieving Treatment Targets in Systemic Lupus Erythematosus

    In this 60-minute activity, participants will improve their ability to assess systemic lupus erythematosus (SLE) disease activity and treatment outcomes by viewing presentations, engaging in a case study, and exploring various measures in a matching exercise. This activity will also help bridge the gap between patients’ perceptions of their disease and healthcare providers’ assessment. The SLE clinical expert and the patient will demonstrate effective patient engagement strategies—in particular, shared decision making using a decision aid—to achieve optimal, measurable therapeutic outcomes that advance care for patients living with SLE.This activity is one of two in the series, Systemic Lupus Erythematosus: Patient-Centered Care to Improve Disease Control.

    Release Date: April 9, 2021
    Valid Until: April 9, 2022

    For the best experience, use a laptop, desktop, or tablet with the Google Chrome browser.